
Opinion|Videos|July 2, 2024
Experts Discuss Long-Term Effects and Monitoring in AD Therapy
Medical experts discuss the long-term consequences of extended use of topical corticosteroids or calcineurin inhibitors in atopic dermatitis (AD) patients and recommend appropriate monitoring strategies.
Advertisement
Episodes in this series

- What are the implications of long-term use of topical corticosteroids or calcineurin inhibitors in AD patients, and how should patients be monitored for these?
- Also discuss how to address concerns related to systemic exposure/absorption of topical corticosteroids
- What factors do you consider when deciding between topical and systemic therapies for patients needing treatment for AD?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
OpenAI for Healthcare Aims to Streamline Clinical Workflows, Reduce Administrative Burden
2
Medical Debt Emerges as Risk Factor for Housing Instability
3
Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data
4
Smarter Vaccination Strategies Could Strengthen Future Influenza Preparedness: Marco del Riccio, MD
5




























































